Olimel N7e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7e provides amino acid supplementation that supports several clinical situations where protein intake is compromised.

• Post‑operative recovery: helps maintain nitrogen balance during healing.
• Chronic kidney disease: assists in managing protein‑energy wasting.
• Severe malnutrition: supports restoration of lean body mass.
• Inborn errors of metabolism: supplies specific amino acids that may be deficient.
• Critical illness: contributes to overall nutritional support in intensive care.

• The formulation supplies a balanced profile of essential and non‑essential amino acids that are directly incorporated into protein synthesis pathways. By providing substrates for the mTOR signaling cascade, it promotes cellular growth and tissue repair while supporting nitrogen balance and metabolic homeostasis.

Amino acid mixtures are generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Abdominal cramping: transient stomach pain.
• Diarrhoea: loose stools, usually self‑limiting.
• Metallic taste: temporary alteration in oral sensation.
• Headache: mild, often resolves without intervention.
• Hyperuricaemia: slight increase in serum uric acid levels.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, or swelling requiring medical attention.
• Hyperammonaemia: elevated blood ammonia in susceptible individuals.
• Metabolic acidosis: rare disturbance in acid‑base balance.
• Severe gastrointestinal bleeding: uncommon but serious.
• Anaphylaxis: immediate hypersensitivity reaction, emergency care needed.

When prescribing Olimel N7e, consider patient‑specific factors and monitor for potential issues.

• Renal impairment: adjust dosage and monitor nitrogen waste products.
• Hepatic dysfunction: assess ammonia levels regularly.
• Pregnancy: limited data; use only if benefits outweigh risks.
• Lactation: excrete into breast milk; evaluate infant safety.
• Drug interactions: review concomitant medications that affect amino acid metabolism.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino acid supplements can influence the pharmacokinetics of certain drugs.

Major Interactions (Avoid)

• Levodopa: may reduce absorption, diminishing therapeutic effect.
• MAO‑inhibitors: risk of hypertensive crisis when combined with high‑tyrosine content.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): may alter plasma amino acid levels.
• Thyroid hormones: potential interference with absorption.
• Antibiotics (tetracyclines, quinolones): chelation reducing efficacy.
• Iron supplements: competitive absorption may lower iron uptake.